A study on valiazhal keelvayu (Rheumatoid arthritis) with varmam therapy,isanguver Thailam (external) and vathasura kudineer (internal).

An open clinical trial to evaluate the effectiveness of varmam therapy along with Vathasura kudineer (internal)and Isanguver thailam(external)for the management of valiazhal keelvayu (Rheumatoid arthritis) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067686

Enrollment

Registered

2024-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS- Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Vathasura kudineer (internal) Isanguver thailam (external) varmam therapy: Internal - 60ml twice a day for 48 days External- 50 ml applied all over the painful joints Varmam therapy -

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient who fulfills the ACR/EULAR criteria 2.Patient willing to sign informed consent 3.Patient willing to provide blood sample for lab investigation

Exclusion criteria

Exclusion criteria: 1.k/c/o Rheumatic fever 2.k/c/o Psoriatic arthritis 3.k/c/o Gouty arthritis 4.k/c/o Septic arthritis 5.Pregnant women and lactating mother

Design outcomes

Primary

Measure	Time frame
Reduction of Clinical symptoms of RA will be assessed by through Modified Health Assessment questionnaire(MHAQ)Timepoint: 8 Weeks	—

Secondary

Measure	Time frame
Quality of life of Valiazhal Keelvayu (RA) patients is assessed by RAQol questionnaire.Timepoint: Assessment of Quality of life - 3 months	—

Countries

India

Contacts

Public ContactDr P Samundeswari

National Institute of Siddha

mdsamuk@gmail.com9445403599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026